- Business
- MeiHua Holdings Group Co., Ltd. (600873.SS) engages primarily in the research, development, production, and sale of amino acid nutrition products and health solutions through biological fermentation technology in China and internationally. The company offers a broad portfolio of core products including feed-grade amino acids such as L-lysine sulphate and HCL, L-threonine, L-tryptophan, and valine; umami agents and condiments like monosodium glutamate (MSG), disodium nucleotide, and guanosine 5'-monophosphate disodium salt; food ingredients encompassing xanthan gum, trehalose, natamycin, and pullulan; pharmaceutical intermediates and grade amino acids including glutamine, proline, leucine, isoleucine, inosine, guanosine, and adenosine; livestock health products; plant-based proteins; bio-based chemicals; DNA synthesis materials; functional food ingredients; proteins and peptides; and plant nutrition solutions such as biological organic fertilizers and soil conditioners. Founded in 1995 and headquartered at No. 66 Huaxiang Road, Langfang Economic and Technological Development Zone, Hebei Province, China, MeiHua operates production facilities including major sites in Tongliao, Inner Mongolia, and Mulitu Industrial Park, serving customers in over 150 countries across five continents with a focus on food additives, feed additives, pharmaceuticals, functional ingredients, and seasonings. In recent developments, the company completed the acquisition of Kyowa Hakko Bio Co., Ltd.'s amino acid and human milk oligosaccharide (HMO) businesses in July 2025 for approximately ¥10.5 billion, enhancing its pharmaceutical amino acids portfolio, fermentation technologies, production capacities, and regulatory approvals in Asia, Europe, and North America; additionally, in February 2025 it upgraded its official website, in October 2024 launched a new brand logo, and in December 2024 achieved carbon footprint and water footprint certifications for its Tongliao MSG products.